HistoSonics announced that its Edison histotripsy system for noninvasively destroying liver tumors has secured early U.K.

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping ...

Abbott (NYSE: ABT) published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless ...